Literature DB >> 17822692

Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes.

Manuel Campos-Toimil1, Jacobo Elíes, Ezequiel Alvarez, Ignacio Verde, Francisco Orallo.   

Abstract

Although the natural polyphenol resveratrol posses a direct vasorelaxant effect, its effects on cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) in vascular cells remain still unclear. Here, we have investigated the effects of the isomers trans- and cis-resveratrol on agonist- and high-K(+)-induced [Ca(2+)](i) increases and on voltage-activated transmembrane Ca(2+) fluxes using imaging and patch-clamp techniques in vascular A7r5 myocytes. Arginine vasopressin (AVP) or angiotensin II caused a biphasic increase in [Ca(2+)](i) that was reduced by preincubation with trans-resveratrol and cis-resveratrol. Both isomers also reduced the agonist-induced increase in [Ca(2+)](i) in absence of extracellular Ca(2+). In high-K(+) Ca(2+)-free solution, reintroduction of Ca(2+) caused a sustained rise in [Ca(2+)](i) that was reduced by preincubation with trans-resveratrol or cis-resveratrol. When the isomers were applied during the plateau phase of the agonist- or the high-K(+)-induced response, a biphasic change in [Ca(2+)](i) was observed: a transient reduction of the plateau (<5 min) followed by an increase (>10 min). Finally, trans-resveratrol and cis-resveratrol inhibited voltage-dependent L-type Ca(2+) currents (I(Ca(L))). In conclusion, resveratrol isomers exert a dual effect on [Ca(2+)](i) handling in A7r5 myocytes: 1) a blockade of I(Ca(L)) and 2) an increase in [Ca(2+)](i) by depletion of intracellular Ca(2+) stores (which interferes with the agonist-induced release of intracellular Ca(2+)) and influx of Ca(2+), mainly due to activation of capacitative Ca(2+) entry, although other Ca(2+)-permeable channels are also involved. Taken together, these effects may explain, in part, the endothelium-independent vasorelaxant effects of resveratrol in rat aorta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822692     DOI: 10.1016/j.ejphar.2007.08.003

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  Activation energy of light induced isomerization of resveratrol.

Authors:  Teresa Sofia Figueiras; Maria Teresa Neves-Petersen; Steffen B Petersen
Journal:  J Fluoresc       Date:  2011-04-15       Impact factor: 2.217

3.  Resveratrol mobilizes Ca2+ from intracellular stores and induces c-Jun N-terminal kinase activation in tumoral AR42J cells.

Authors:  Lourdes Garcia-Sanchez; Patricia Santofimia-Castaño; Alvaro Miro-Moran; Jose A Tapia; Gines M Salido; Antonio Gonzalez
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

4.  Resveratrol Interferes with Fura-2 Intracellular Calcium Measurements.

Authors:  Richard F Kopp; Colin A Leech; Michael W Roe
Journal:  J Fluoresc       Date:  2013-10-23       Impact factor: 2.217

5.  Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Maira Shahid; John W Rose; Noel G Carlson; Ikuo Tsunoda
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

6.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

Review 7.  Resveratrol and calcium signaling: molecular mechanisms and clinical relevance.

Authors:  Audrey E McCalley; Simon Kaja; Andrew J Payne; Peter Koulen
Journal:  Molecules       Date:  2014-06-05       Impact factor: 4.411

8.  Resveratrol increases nitric oxide production in the rat thick ascending limb via Ca2+/calmodulin.

Authors:  Agustin Gonzalez-Vicente; Pablo D Cabral; Jeffrey L Garvin
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

Review 9.  Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol.

Authors:  Shereen M Hamza; Jason R B Dyck
Journal:  Front Physiol       Date:  2014-08-05       Impact factor: 4.566

Review 10.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.

Authors:  J Gambini; M Inglés; G Olaso; R Lopez-Grueso; V Bonet-Costa; L Gimeno-Mallench; C Mas-Bargues; K M Abdelaziz; M C Gomez-Cabrera; J Vina; C Borras
Journal:  Oxid Med Cell Longev       Date:  2015-06-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.